Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate plus betamethasone for plaque psoriasis
IRCT2016010312782N9Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of methotrexate and betamethasone in plaque psoriasis, sponsored by Isfahan University of Medical Sciences. Started May 2016; status: completed.
02
Drugs
methotrexatebetamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on IRCT2016010312782N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016010312782N9.